文献速递炎症性肠病消化内镜

床旁胃肠超声对炎症性肠病决策与管理的影响

Effect of point-of-care gastrointestinal ultrasound on decision-making and management in inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2021-06-22

一项前瞻性观察性队列研究纳入259例成人炎症性肠病患者,由临床医生决定是否接受床旁胃肠超声检查。超声后患者对疾病的理解和决策信心改善,临床医生对22%患者的疾病活动度评估发生改变,56%患者的管理方案被调整,抗炎治疗升级占33%。

要点

  • 床旁胃肠超声可改变临床医生对炎症性肠病疾病活动度的评估和治療决策。
  • 超声组患者对疾病理解和决策信心改善,但自我管理能力无影响。
  • 克罗恩病和溃疡性结肠炎患者超声组药物调整比例均高于非超声组。

核心结论

  • 床旁胃肠超声有潜力通过辅助临床医生决策和患者教育来增强炎症性肠病的临床管理。

研究设计与样本

  • 前瞻性观察性队列研究,利用常规门诊就诊,纳入259例成人炎症性肠病患者,由治疗临床医生决定是否接受胃肠超声。

主要发现

  • 超声后临床医生对患者疾病活动度的评估在22%(16/73)患者中发生改变。
  • 超声后56%(41/73)患者的管理方案被调整,其中33%抗炎治疗升级。
  • 克罗恩病患者超声组药物调整比例为47%(23/49),非超声组为22%(25/112),P=0.002。
  • 溃疡性结肠炎患者超声组药物调整比例为68%(15/22),非超声组为26%(24/70),P=0.005。
  • 按疾病活动度分层后,接受超声者更可能发生药物调整(P=0.024)。

临床怎么用

  • 床旁胃肠超声可作为炎症性肠病门诊评估工具,辅助临床医生决策并促进患者对疾病的理解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastrointestinal ultrasound is increasingly used for point of care assessment of inflammatory bowel disease. AIMS: To explore the utility of gastrointestinal ultrasound as a point-of-care assessment tool from the perspectives of the clinician and patient. METHODS: A prospective, observational cohort study was designed utilising routine outpatient consultations. Adult patients with inflammatory bowel disease were allocated to receive gastrointestinal ultrasound or not at the discretion of their treating clinician. Patients completed self-reported session experience questionnaires at study entry, immediately after their consultation, and 4 and 16 weeks later. Clinicians reported disease activity status, therapeutic decisions and clinical management. RESULTS: Of 259 participants, mean age 40 (SD: 13) years, 54% male, 73 (28%) underwent ultrasound. Time since diagnosis was 9.2 (8.5) years (ultrasound) and 11.3 (9.2) years (no ultrasound). Immediately after ultrasound, patients who self-reported active disease reported better understanding of all aspects of their disease and disease symptoms were more confident in their ability to make informed decisions about managing their disease and had improved knowledge domain scores compared with the non-ultrasound group (all P < 0.05). Ultrasound had no influence over the patients' ability to manage their own healthcare but tended to be associated with transient improvement in medication adherence. After the ultrasound, the clinician's assessment of patient's disease activity changed in 22% (16/73) and management was altered in 56% (41/73) with anti-inflammatory therapy escalated in 33. About 47% (23/49) patients with Crohn's disease had their medication changed in the ultrasound group, compared to only 22% (25/112) in the nonultrasound group (P = 0.002). For patients with ulcerative colitis, medications were altered in 68% (15/22) compared to 26% (24/70) in the nonultrasound group (P = 0.005) When stratified for disease activity, medication change was more likely in those having ultrasound (P = 0.024). CONCLUSIONS: Point-of-care gastrointestinal ultrasound has the potential to enhance the clinical management of inflammatory bowel disease by contributing to clinician decision-making and education of patients regarding their disease.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Friedman AB, Asthana A, Knowles SR, et al. Effect of point-of-care gastrointestinal ultrasound on decision-making and management in inflammatory bowel disease. Aliment Pharmacol Ther. 2021. PMID: 34157157. doi:10.1111/apt.16452

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。